Erhöhte Leberwerte

Axel Holstege

doi:10.1055/a-1410-1677

Zeitschrift für Komplementärmedizin, Table of Contents

Zeitschrift für Komplementärmedizin 2021; 13(02): 54-61
DOI: 10.1055/a-1410-1677

Wissen

Refresher

Erhöhte Leberwerte

Axel Holstege∗

Abstract

Summary

Erhöhte Leberwerte sind ein häufiger klinischer Befund, der bei symptomatischen Patienten, aber auch als symptomloser Zufallsbefund auftreten kann. Der vorliegende Beitrag erläutert, wie das Muster bestimmter pathologisch veränderter Leberwerte bereits eine erste differenzialdiagnostische Eingliederung ermöglicht und in welchen Fällen eine weiterführende Diagnostik notwendig ist.

Keywords

Refresher - Leberwerte

Full Text

References

Literatur
1 Holstege A. Überraschende Transaminasenerhöhung. MMW-Fortschr Med 2014; 156: 62-63
2 Vogt W, Holstege A. Problem: Abklärung mäßig erhöhter Transaminasen und γ-GT. In: Schölmerich J, Bischoff SC, Manns MP, Hrsg. Diagnostik in der Gastroenterologie und Hepatologie. Stuttgart: Thieme;; 1997: 151-160
3 Willson RA, Clayson KJ, Leon S. Unmeasurable serum alkaline phosphatase activity in Wilson's disease associated with fulminant hepatic failure and hemolysis. Hepatology 1987; 7: 613-615
4 Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology 1988; 95: 734-739
5 Patel K, Bedossa P, Castera L. Diagnosis of liver fibrosis: Present and future. Semin Liver Dis 2015; 35: 166-183
6 Triger DR, Wright R. Hyperglobulinaemia in liver disease. Lancet 1973; 1 7818 1494-1496
7 Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis E virus infection. Gastroenterology 2012; 142: 1388-1397
8 Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis – Update 2015. J Hepatol 2015; 62 (Suppl. 01) S100-111
9 Bacon BR, Adams PC, Kowdley KV. et al Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54: 328-343
10 Ioannou GN, Dominitz JA, Weiss NS. et al The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology 2004; 126: 1293-1301
11 Bomford A. Genetics of haemochromatosis. Lancet 2002; 360 9346 1673-1681
12 Sarigianni M, Liakos A, Vlachaki E. et al Accuracy of magnetic resonance imaging in diagnosis of liver iron overload: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015; 13: 55-63
13 Roberts EA, Schilsky ML. American Association for the Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: An update. Hepatology 2008; 47: 2089-2111
14 Fontana RJ, Seeff LB, Andrade RJ. et al Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop. Hepatology 2010; 52: 730-742
15 Holstege A. Leberschäden durch Medikamente. Kapitel 6.7.2. In: Messmann H, Hrsg. Klinische Gastroenterologie. Stuttgart: Thieme;; 2012: 599-605
16 Li J, Zhang YL, Chen R. et al Elevated serum liver enzymes in patients with obstructive sleep apnea-hypopnea syndrome. Chin Med J 2015; 128: 2983-2987
17 Kiladjian JJ, Cervantes F, Leebeek FW. et al The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: A report on 241 cases. Blood 2008; 111: 4922-4929
18 McDonald GB, Hinds MS, Fisher LD. et al Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267
19 Kechagias S, Ernersson A, Dahlqvist O. et al Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut 2008; 57: 649-654
20 Rogal SS, Ukomadu C, Levy BD. et al A sweet source of abdominal pain. N Engl J Med 2011; 364: 1762-1767
21 Beuers U, Gershwin ME, Gish RG. et al Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'. Clin Res Hepatol Gastroenterol 2015; 39: e57-e59
22 Marzorati S, Invernizzi P, Lleo A. Making sense of autoantibodies in cholestatic liver diseases. Clin Liver Dis 2016; 20: 33-46
23 Schwarze C, Terjung B, Lilienweiss P. et al IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis. Clin Exp Immunol 2003; 133: 283-289
24 Holstege A, Zolinski P, Woidy L. et al The patient with unexplained elevated serum liver enzymes. Best Pract Res Clin Gastroenterol 2007; 21: 535-550
25 Boonstra K, Culver EL, de Buy Wenniger LM. et al Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology 2014; 59: 1954-1963
26 Beuers U, Hubers LM, Doorenspleet M. et al IgG4-associated cholangitis – A mimic of PSC. Dig Dis 2015; 33 (Suppl. 02) 176-180
27 Ziol M 1, Barbu V, Rosmorduc O. et al ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults. Gastroenterology 2008; 135: 131-141
28 Boyer JL. Bile formation and secretion. Compr Physiol 2013; 3: 1035-1078
29 Jangouk P, Hashash JG. An unusual cause of painless jaundice. Renal cell carcinoma (Stauffer syndrome). Gastroenterology 2014; 146: 913, 1138
30 Lammert F, Neubrand MW, Bittner R. et al S3-Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten und der Deutschen Gesellschaft für Viszeralchirurgie zur Diagnostik und Behandlung von Gallensteinen. Z Gastroenterol 2007; 45: 971-1001
31 Zimmer V, Lammert F. Acute bacterial cholangitis. Viszeralmedizin 2015; 31: 166-172
32 Burt AD, Lackner C, Tiniakos DG. Diagnosis and assessment of NAFLD: Definitions and histopathological classification. Semin Liver Dis 2015; 35: 207-220
33 Tannapfel A, Denk H, Dienes HP. et al Histopathologische Diagnose der nicht alkoholischen und alkoholischen Fettlebererkrankung. Z Gastroenterol 2010; 48: 486-498
34 Musso G, Gambino R, Cassader M. et al Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43: 617-649
35 Newsome PN, Sasso M, Deeks JJ. et al FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol 2020; 5: 362-373
36 Eddowes PJ, Sasso M, Allison M. et al Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 2019; 156: 1717-1730
37 Holstege A. Leberschäden durch Alkohol. Kapitel 6.7.1. In: Messmann H, Hrsg. Klinische Gastroenterologie. Stuttgart: Thieme;; 2012: 594-599
38 Alte D, Luedemann J, Rose HJ. et al Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: Results from the Study of Health in Pomerania (SHIP). Alcohol Clin Exp Res. 2004; 28: 931-940
39 Strobel D, Bernatik T, Blank W. et al Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20 mm) and subcentimetric (≤ 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall Med 2011; 32: 593-597
40 Lazo M, Selvin E, Clark JM. Brief communication: Clinical implications of short-term variability in liver function test results. Ann Intern Med 2008; 148: 348-352
41 Pratt DS, Kaplan MM.. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000; 342: 1266-1271